Prosecution Insights
Last updated: May 29, 2026

Examiner: FUBARA, BLESSING M

Tech Center 1600 • Art Units: 1613 1615 1618

This examiner grants 62% of resolved cases

Performance Statistics

61.9%
Allow Rate
+1.9% vs TC avg
1,310
Total Applications
+34.3%
Interview Lift
1197
Avg Prosecution Days
Based on 1276 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
6.0%
§102 Novelty
47.5%
§103 Obviousness
5.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18977210 Ribociclib Tablet Non-Final OA Novartis AG
18248615 COMPOSITIONS AND METHODS PROMOTING GROWTH OF PERIPHERAL NERVOUS TISSUE Non-Final OA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
19186888 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION Non-Final OA Texas Tech University System
17909480 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION Non-Final OA Texas Tech University System
18544330 TWO-STEP CLEANSING METHOD Non-Final OA L'OREAL
17623348 COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUND Non-Final OA L'OREAL
18428820 COMPOSITION FOR TREATING GOUT CONTAINING CYCLODEXTRIN-CONJUGATED POLYMER NANO-DRUG AND METHOD FOR TREATING GOUT Final Rejection The General Hospital Corporation
18198154 Compositions to Modify Intestinal Nutrient Absorption, Methods of Making and Uses Thereof Non-Final OA McMaster University
17738764 CONTROLLING THE SIZE OF 3D PRINTING HYDROGEL OBJECTS USING HYDROPHILIC MONOMERS, HYDROPHOBIC MONOMERS, AND CROSSLINKERS Non-Final OA Lung Biotechnology PBC
17787016 USE OF DEHYDROASCORBIC ACID AGAINST NEMATODE INFECTION IN PLANTS Non-Final OA Universiteit Gent
17896758 PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE Non-Final OA Chugai Seiyaku Kabushiki Kaisha
18682911 Topical Compositions and Formulations with Multifunctional Actions, Including Activity Against Parasites Non-Final OA BIOSAFE TECHNOLOGIES, INC.
18682112 PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Non-Final OA Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
18577690 COMPOSITION CONTAINING LOXOPROFEN SODIUM Final Rejection OCUSUN OPHTHALMIC PHARMACEUTICAL (GUANGZHOU) CO., LTD.
18275257 METHOD FOR PREPARING LOW-MOLECULAR-WEIGHT SILK SERICIN, AND COSMETIC COMPOSITION COMPRISING SERICIN PREPARED THEREBY Final Rejection HEWON CO., LTD.
18574987 ORAL POUCH FOR DELIVERING ACTIVE INGREDIENTS Final Rejection pely-tex GmbH & Co. KG
18391074 BIOPOLYMER SCAFFOLDS AND METHODS FOR PRODUCTION OR USE THEREOF Non-Final OA Bionova Medical, Inc.
18485087 NATURAL COMPOSITIONS FOR USE IN TREATMENT OF GENITAL INFECTIONS Final Rejection Organicare LLC
18242206 LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR Non-Final OA RxSight, Inc.
18119693 THROMBORESISTANT COATINGS, COATED DEVICES, AND METHODS Non-Final OA Surmodics Coatings, LLC
17633678 GINGIVAL GRAFT Non-Final OA CORNEAT VISION LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month